Exeliom Biosciences

OverviewSuggest Edit

Exeliom Biosciences (formerly Nextbiotix) is a biotechnology company developing monoclonal microbial therapies. Its lead candidate, a mono-strain product, uses Faecalibacterium prausnitzii to treat inflammatory bowel diseases, etc.
TypePrivate
Founded2016
HQDijon, FR
Websiteexeliombio.com

Locations

Exeliom Biosciences is headquartered in
Dijon, France

Location Map

Latest Updates

Employees (est.) (Nov 2020)3
Cybersecurity ratingAMore

Exeliom Biosciences Office Locations

Exeliom Biosciences has offices in Dijon and Paris
Dijon, FR (HQ)
67 Rue des Godrans
Paris, FR
24 Rue du Faubourg Saint-Jacques
Show all (2)

Exeliom Biosciences Financials and Metrics

Summary Metrics

Founding Date

2016

Exeliom Biosciences total Funding

$8.2 m

Exeliom Biosciences latest funding size

$8.22 m

Time since last funding

2 years ago

Exeliom Biosciences investors

Exeliom Biosciences's latest funding round in July 2018 was reported to be $8.2 m. In total, Exeliom Biosciences has raised $8.2 m
Show all financial metrics

Exeliom Biosciences Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

SecurityScorecard logo

Exeliom Biosciences Online and Social Media Presence

Embed Graph

Exeliom Biosciences Frequently Asked Questions

  • When was Exeliom Biosciences founded?

    Exeliom Biosciences was founded in 2016.

  • How many employees does Exeliom Biosciences have?

    Exeliom Biosciences has 3 employees.

  • Who are Exeliom Biosciences competitors?

    Competitors of Exeliom Biosciences include Pandion Therapeutics, Kymera Therapeutics and MedDay.

  • Where is Exeliom Biosciences headquarters?

    Exeliom Biosciences headquarters is located at 67 Rue des Godrans, Dijon.

  • Where are Exeliom Biosciences offices?

    Exeliom Biosciences has offices in Dijon and Paris.

  • How many offices does Exeliom Biosciences have?

    Exeliom Biosciences has 2 offices.